AKEBIA THERAPEUTICS, INC. Preferred Stock, Accretion of Redemption Discount
AKEBIA THERAPEUTICS, INC. (AKBA) reported Preferred Stock, Accretion of Redemption Discount of $86.90 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-06.
Discontinued › Shareholders' Equity
us-gaap:PreferredStockAccretionOfRedemptionDiscount · last filed 2017-03-06
- AKEBIA THERAPEUTICS, INC. preferred stock, accretion of redemption discount for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. preferred stock, accretion of redemption discount for the quarter ending 2014-03-31 was $86.90M, a 10146.08% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. preferred stock, accretion of redemption discount for the quarter ending 2013-06-30 was $49.27M.
- AKEBIA THERAPEUTICS, INC. preferred stock, accretion of redemption discount for the quarter ending 2013-03-31 was $848.13K.
- AKEBIA THERAPEUTICS, INC. preferred stock, accretion of redemption discount for fiscal 2014 was $86.90M, a 55.50% increase from fiscal 2013.
- AKEBIA THERAPEUTICS, INC. preferred stock, accretion of redemption discount for fiscal 2013 was $55.89M, a 1581.79% increase from fiscal 2012.
- AKEBIA THERAPEUTICS, INC. preferred stock, accretion of redemption discount for fiscal 2012 was $3.32M.
| Period end | Preferred Stock, Accretion of Redemption Discount 3 month | Preferred Stock, Accretion of Redemption Discount 6 month | Preferred Stock, Accretion of Redemption Discount 12 month | Preferred Stock, Accretion of Redemption Discount 85 month |
|---|---|---|---|---|
| 2014-12-31 | $86.90M 10-K · filed 2017-03-06 | |||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $86.90M 10-Q · filed 2014-08-11 | ||
| 2014-03-31 | $86.90M 10-Q · filed 2014-05-12 | $153.64M 10-Q · filed 2014-05-12 | ||
| 2013-12-31 | $55.89M 10-K · filed 2016-03-14 | |||
| 2013-06-30 | $49.27M 10-Q · filed 2014-08-11 | $50.11M 10-Q · filed 2014-08-11 | ||
| 2013-03-31 | $848.13K 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | $3.32M 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |